XML 28 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jul. 31, 2021
Jul. 31, 2020
Jan. 31, 2021
Jan. 31, 2020
Jan. 31, 2019
Cash flows from operating activities          
Net income (loss) $ (2,649) $ (65,385) $ (197,024) $ (134,327) $ (108,087)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization 5,576 4,684 10,083 7,698 4,086
Non-cash operating lease cost 1,963 1,749 3,762 3,121 0
Stock-based compensation 35,870 2,100 4,947 2,937 1,706
Amortization of deferred contract acquisition costs 829 538 1,206 675 0
Change in fair value of redeemable convertible preferred stock warrant liability (9,237) 10,981 73,125 875 388
Change in fair value of common stock warrant liabilities (33,340) 10,981      
Change in fair value of contingent earnout liability (84,420)        
Inventory reserves     1,412 1,425 1,089
Transaction costs expensed 7,031        
Other 1,236 683 446 589 1,822
Changes in operating assets and liabilities, net of effect of acquisitions:          
Accounts receivable, net (7,657) 16,188 3,292 (8,702) (2,735)
Inventories 5,620 (7,427) (9,585) (1,472) (19,457)
Prepaid expenses and other assets (9,325) (3,335) (8,914) (2,961) (1,760)
Operating lease liabilities (953) (2,031) (2,815) (1,181) 0
Accounts payable 9,293 (9,324) (493) 15,704 (1,120)
Accrued and other liabilities 3,027 (4,054) 11,556 93 10,802
Deferred revenue 15,938 4,564 17,156 27,590 12,720
Net cash used in operating activities (61,198) (50,069) (91,846) (87,936) (100,546)
Cash flows from investing activities          
Purchases of property and equipment (7,788) (5,962) (11,484) (14,885) (14,822)
Purchases of investments     0 (179,514) 0
Maturities of investments   47,014 47,014 132,500 0
Cash paid for acquisition, net of cash acquired     0 0 (1,475)
Net cash (used in) provided by investing activities (7,788) 41,052 35,530 (61,899) (16,297)
Cash flows from financing activities          
Proceeds from the exercise of public warrants 117,598 31,390      
Proceeds from issuance of redeemable convertible preferred stock   92,433 95,456 14,756 215,168
Merger and PIPE financing 511,646        
Proceeds from issuance of common stock warrants     31,547 185 1,454
Payment of transaction costs related to Merger (32,468)        
Proceeds from issuance of debt, net of issuance costs     0 0 33,988
Payment of tax withholding obligations on settlement of earnout shares (20,894)        
Payments of deferred offering costs     (4,003) 0 0
Repayment of borrowings (36,051)        
Repayment of debt     0 0 (18,182)
Proceeds from exercises of vested and unvested stock options 1,759 1,542 5,913 2,217 1,370
Net cash provided by financing activities 541,590 125,365 128,913 17,158 233,798
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (6) 36 141 132 (101)
Net increase in cash, cash equivalents, and restricted cash 472,598 116,384 72,738 (132,545) 116,854
Cash, cash equivalents, and restricted cash at beginning of period 145,891 73,153 73,153 205,698 88,844
Cash, cash equivalents, and restricted cash at end of period 618,489 189,537 145,891 73,153 205,698
Supplementary cash flow information          
Cash paid for interest 344 1,402 2,801 3,414 2,583
Cash paid for taxes 115 105 172 153 117
Supplementary cash flow information on noncash investing and financing activities          
Accretion of beneficial conversion feature of redeemable convertible preferred stock   $ 58,625 60,377 0 0
Deferred transaction costs not yet paid     1,685 0 0
Right-of-use assets obtained in exchange for lease liabilities     2,118 2,906 0
Right-of-use asset remeasurement subsequent to lease extension     12,867 0 0
Vesting of early exercised stock options     268 15 4
Acquisitions of property and equipment included in accounts payable and accrued and other current liabilities     $ 647 $ 1,287 $ 0
Conversion of redeemable convertible preferred stock into common stock in connection with the reverse recapitalization 615,697        
Reclassification of Legacy ChargePoint redeemable convertible preferred stock warrant liability upon the reverse capitalization 66,606        
Contingent earnout liability recognized upon the closing of the reverse recapitalization 828,180        
Reclassification of remaining contingent earnout liability upon triggering event $ 242,640